HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 10, October 2020 – Artificial Intelligence Technologies — Helping the Fight Against COVID-19s       » Improving Sensitivity of Optical Receivers for Space Communication       » Genetic Variants Identified for the Susceptibility to Neuroblastoma       » Novo Nordisk Launches New Treatment for Diabetes in Singapore       » SMART Researchers Find New Way to Make Bacteria More Sensitive to Antibiotics       » Study Finds Liver Injury to be Common Among COVID-19 Patients      
Vol 19, No. 09, September 2015   |   Issue PDF view/purchase
EDITOR'S LETTER
 

The ASEAN Economic Community — Challenges and Opportunities for Healthcare Companies

The idea of creating an integrated economic bloc amongst the members of the Association of Southeast Asian Nations (ASEAN) was first mooted in the early 2000s. Since then, the formation of the ASEAN Economic Community or AEC has become a reality, although at a slower pace than what its proponents had envisioned. Still, this is an important endeavour because its success, even partially, can help spur the region’s economic, social and political developments.

Healthcare is a priority sector that the various ASEAN governments have identified for region-wide integration. It is therefore an important part of the AEC. The AEC’s formation is expected to further accelerate the growth of the region’s healthcare industry. This will be driven by additional foreign direct investments, freer flow of trade, manpower and capital within ASEAN, as well as the growing affluence among ASEAN countries.

Within this context, I had the opportunity to approach individuals who are deeply involved in the healthcare business in Asia and ask them to share their thoughts. The formation of the AEC will no doubt impact the activities of their companies and organisations in different ways, and their views of this development could be of interests to others who are looking to the ASEAN’s healthcare markets.

This section opens with an article by Dr Derrick Tan, the director of AsiaPac Bio LLP, and who has been involved in the life sciences industry in Singapore and Asia since the late 1990s. Derrick provides an overview of ASEAN’s healthcare market potential and suggest how business can grow in the region through Singapore. The remaining articles cover related topics and will provide snapshots of the opportunities and challenges facing organisations in biopharmaceuticals, medical devices and healthcare services sectors in this new environment. Hopefully, this will pique your interest sufficiently to find out more, leading to future endeavours in the ASEAN healthcare markets.

Marvin Ng
Principal Consultant, DN Venture Partners LLP

Marvin is principal consultant at DN Venture Partners LLP (www.dn-venture.com), a Singapore-based business development consulting firm that helps private and public organisations in the life sciences industry expand their business activities into Asia and beyond. He is also the co-editor of the Singapore Biotech Guide and the Singapore Medtech Portal.
NEWS CRUNCH  
news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy